These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 24418856

  • 1. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
    Surrey LF, Frank R, Zhang PJ, Furth EE.
    Am J Surg Pathol; 2014 Feb; 38(2):224-7. PubMed ID: 24418856
    [Abstract] [Full Text] [Related]

  • 2. TTF-1 and Napsin-A Are Not Markers for Biliary Phenotype: An Immunohistochemical Study of Gallbladder Adenocarcinomas.
    Roy M, Jain D, Yadav R, Mathur SR, Iyer VK.
    Am J Surg Pathol; 2015 Dec; 39(12):1742-4. PubMed ID: 26559378
    [No Abstract] [Full Text] [Related]

  • 3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 4. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W.
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [Abstract] [Full Text] [Related]

  • 5. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A, Wittekind C.
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [Abstract] [Full Text] [Related]

  • 6. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
    Vasuri F, Rocchi L, Degiovanni A, Giunchi F, Brandi G, Treré D, Montanaro L, D'Errico-Grigioni A.
    Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
    [Abstract] [Full Text] [Related]

  • 7. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J, Liu H, Ma XJ, Chen Z, He MX, Luo Y, Lin F.
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [Abstract] [Full Text] [Related]

  • 8. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
    Liu L, Cohen C, Siddiqui MT.
    Acta Cytol; 2012 Apr; 56(4):425-30. PubMed ID: 22846220
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
    Maeda T, Taguchi K, Aishima S, Shimada M, Hintz D, Larusso N, Gores G, Tsuneyoshi M, Sugimachi K, Wands JR, de la Monte SM.
    Cancer Detect Prev; 2004 Apr; 28(5):313-8. PubMed ID: 15542253
    [Abstract] [Full Text] [Related]

  • 10. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R, Wang Y, Chen L, Gurda GT, Geddes S, Gabrielson E, Askin F, Li QK.
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [Abstract] [Full Text] [Related]

  • 11. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L, Chen W, Liang P, Hu W, Zhang K, Shen S, Chen J, Zhang Z, Chen B, Han Y, Meng F, DeMorrow S, Yin X, Lai J, Liang L.
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [Abstract] [Full Text] [Related]

  • 12. Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm. A new view on so-called "hepatoid adenocarcinoma of the gallbladder".
    Dettoni JB, Andrauss W, Theise ND, Rocha MS, Mello ES, Rocha CH, Pfiffer TE, Alves VA.
    Pathologica; 2014 Mar; 106(1):7-13. PubMed ID: 24897774
    [Abstract] [Full Text] [Related]

  • 13. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
    El-Maqsoud NM, Tawfiek ER, Abdelmeged A, Rahman MF, Moustafa AA.
    Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
    [Abstract] [Full Text] [Related]

  • 14. Thyroid Transcription Factor-1 Expression in Adenocarcinomas of the Bile Duct.
    Lino-Silva LS, Salcedo-Hernández RA, García-Gómez MA, Ruiz-García EB, Aguilar-Romero JM, Domínguez-Rodríguez JA, Herrera-Gómez Á, Maldonado-Martínez HA.
    Int J Surg Pathol; 2016 Feb; 24(1):24-8. PubMed ID: 26316052
    [Abstract] [Full Text] [Related]

  • 15. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
    Iwamoto M, Nakatani Y, Fugo K, Kishimoto T, Kiyokawa T.
    Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
    [Abstract] [Full Text] [Related]

  • 16. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.
    Jarnagin WR, Klimstra DS, Hezel M, Gonen M, Fong Y, Roggin K, Cymes K, DeMatteo RP, D'Angelica M, Blumgart LH, Singh B.
    J Clin Oncol; 2006 Mar 01; 24(7):1152-60. PubMed ID: 16505435
    [Abstract] [Full Text] [Related]

  • 17. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
    Mosnier JF, Kandel C, Cazals-Hatem D, Bou-Hanna C, Gournay J, Jarry A, Laboisse CL.
    Mod Pathol; 2009 Feb 01; 22(2):182-90. PubMed ID: 18622386
    [Abstract] [Full Text] [Related]

  • 18. Surgical management of cholangiocarcinoma.
    Jarnagin WR, Shoup M.
    Semin Liver Dis; 2004 May 01; 24(2):189-99. PubMed ID: 15192791
    [Abstract] [Full Text] [Related]

  • 19. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H.
    Appl Immunohistochem Mol Morphol; 2011 Jul 01; 19(4):313-7. PubMed ID: 21464700
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
    Terra SB, Aubry MC, Yi ES, Boland JM.
    Hum Pathol; 2014 Feb 01; 45(2):294-302. PubMed ID: 24331839
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.